Segluromet

Active Ingredient(s): Ertugliflozin + Metformin Hydrochloride
FDA Approved: * December 19, 2017
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Segluromet Overview

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes,[4][5] particularly in people who are overweight.[6] It is also used in the treatment of polycystic ovary syndrome.[4] Limited evidence suggests metformin may prevent the cardiovascular disease and cancer complications of diabetes.[7][8] It is not associated with weight gain.[8] It is taken by mouth.[4] Metformin is generally well tolerated.[9] Common side effect...

Read more Segluromet Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metformin

Recent Segluromet Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Segluromet: (4 results)

Sorted by National Drug Code

• 0006-5369 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
• 0006-5370 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
• 0006-5373 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
• 0006-5374 Segluromet Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Drugs with one or more similar ingredients: (26 results)